JNJ

270.4701.25%
JD

Joaquin Duato

CEO & Chairman

Mr. Joaquin Duato serves as Chief Executive Officer & Director of Johnson & Johnson since January 3, 2022 and serves as its Chairman since January 02, 2023. He served as Worldwide Chairman of Pharmaceuticals at Johnson & Johnson since January 3, 2011 and its Executive Vice President since April 9, 2016. Mr. Duato is responsible for the Pharmaceuticals and Consumer sectors, as well as Supply Chain, IT, Global Services and the Health and Wellness businesses. He served as Group Chairman of Johnson & Johnson until January 3, 2011. He served as a Trustee of Save The Children Federation, Incorporated since 2012. He is responsible for the global commercial businesses of the Janssen Pharmaceutical Companies of Johnson & Johnson. Mr. Duato oversees the Operations, Quality and Compliance functional groups that support the pharmaceutical Commercial and Research & Development organizations. Previously, he was Company Group Chairman, Ortho Clinical Diagnostics, Inc., once a Johnson & Johnson company in the Medical Devices & Diagnostics segment. His professional experience in the healthcare industry spans sales, marketing and general management. He began his career at Johnson & Johnson in 1989 with Janssen-Cilag Spain and later became Managing Director of Janssen-Cilag Italy. He then led Ortho Biotech Europe before relocating to the United States in 2002 to serve as President, Ortho Biotech Products, L.P. in 2005. A native of Valencia, Spain, Joaquin holds an undergraduate degree in economics and two master’s degrees — one in business administration from ESADE Business School in Barcelona; the other in international management from Thunderbird in Phoenix, Arizona. Joaquin is a Member of the Board of Directors of the Pharmaceutical Research & Manufacturers of America (PhRMA). He serves as elected Treasurer and Chair of the State Committee. He is also a Member of the Board of the European Federation of the Pharmaceutical Industry and Associations (EFPIA), the Board of Trustees of Save the Children and the International Advisory Board of the ESADE Business School. He is a past Chair of PhRMA and sits on the boards of UNICEF USA and Tsinghua University School of Pharmaceutical Sciences. He served as Independent Director of Hess Corporation until January 27, 2022. As the current executive sponsor of Johnson & Johnson’s African Ancestry Leadership Council, Honorable Mentor award. He earned an MBA from ESADE in Barcelona, Spain and a Master of International Management from Thunderbird School of Global Management in Phoenix, Arizona.

Positions